Streetbeat News

Price Targets

INDV

Piper Sandler analyst David Amsellem has reiterated an Overweight rating on Indivior (NASDAQ:INDV) but has lowered the price target from $22 to $15.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 2:12 pm

DAR

Piper Sandler analyst Ryan Todd maintains an Overweight rating on Darling Ingredients (NYSE:DAR) but lowers the price target from $50 to $48.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 2:10 pm

IDXX

JP Morgan analyst Chris Schott maintains an Overweight rating on IDEXX Laboratories but lowers the price target from $630 to $575.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 2:10 pm

ELF

JP Morgan analyst Andrea Teixeira maintains an Overweight rating on e.l.f. Beauty but lowers the price target from $207 to $167.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 2:08 pm

DPZ

JP Morgan analyst John Ivankoe maintains a Neutral rating on Domino's Pizza (NYSE:DPZ) and lowers the price target from $470 to $450.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 2:06 pm

DNLI

JP Morgan analyst Jessica Fye maintains an Overweight rating on Denali Therapeutics but lowers the price target from $29 to $28.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 2:04 pm

MNPR

Rodman & Renshaw has initiated coverage on Monopar Therapeutics with a Buy rating and set a price target of $50.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 2:04 pm

CSTM

JP Morgan analyst Bill Peterson maintains an Overweight rating on Constellium (NYSE:CSTM) but lowers the price target from $25 to $24.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 2:02 pm

AMD

Piper Sandler has maintained an Overweight rating on Advanced Micro Devices (AMD) and raised its price target from $175 to $200, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 2:02 pm

MANH

In the last three months, analysts have shown a positive shift in sentiment towards Manhattan Associates (NASDAQ:MANH), with several raising their price targets. The average 12-month price target has increased by 9.56% to $286.4. The company has demonstrated strong financial performance with notable revenue growth and profitability metrics.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 2:01 pm